ARCHIVES

ODAC Recommends Femara Campath For FDA Approval.

This article is from The Cancer Letter archive.

Vol. 27 No. 01 | January 5, 2001

Download PDF Visit The Full Archive

Related Articles

NHIS Cancer Control Supplement To Survey 52,000

October 4, 1985

In Brief: Richard Fisher Named Fox Chase President and CEO

August 2, 2013

Funding opportunities listed.

January 16, 2004

NAS To Honor Outstanding Scientists

February 28, 1997

NCI-Approved Clinical Trials

January 27, 2006

FDA Approves Lapatinib For Advanced Breast Cancer

March 30, 2007